Immunoglobulin A antibodies against ricin A and B subunits protect epithelial cells from ricin intoxication

Infection and Immunity

Volumn 74, Issue 6, 2006, Pages 3455-3462

  Mantis, Nicholas J ^a   McGuinness, Carolyn R ^a   Sonuyi, Oluwakemi ^b   Edwards, Gary ^a   Farrant, Stephanie A ^b  

^a WADSWORTH CENTER   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; INTERLEUKIN 8; LECTIN; RIBOSOME INACTIVATING PROTEIN; RICIN; RICIN A; RICIN B; UNCLASSIFIED DRUG; VEROTOXIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; CELL PROTECTION; CELL TRANSPORT; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; EPITHELIUM CELL; FEMALE; GASTROINTESTINAL TRACT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNIZATION; IN VITRO STUDY; IN VIVO STUDY; INTESTINE EPITHELIUM CELL; INTOXICATION; MACROPHAGE; MESENTERY LYMPH NODE; MONOCYTE; MONOLAYER CULTURE; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PEYER PATCH; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RESPIRATORY SYSTEM; TISSUE SECTION; TRANSCYTOSIS;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL POLARITY; CERCOPITHECUS AETHIOPS; EPITHELIAL CELLS; EPITOPE MAPPING; FEMALE; GALACTOSIDES; HUMANS; IMMUNOGLOBULIN A; MICE; MICE, INBRED BALB C; PROTEIN SUBUNITS; PROTEIN TRANSPORT; RICIN; VERO CELLS;

EID: 33646905629     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.02088-05     Document Type: Article

References (47)

1. Apter, F. M., W. I. Lencer, R. A. Finkelstein, J. J. Mekalanos, and M. R. Neutra. 1993. Monoclonal immunoglobulin A antibodies directed against cholera toxin prevent the toxin-induced chloride secretory response and block toxin binding to intestinal epithelial cells in vitro. Infect. Immun. 61:5271-5278.
2. Atlas, R. M. 2002. Bioterrorism: from threat to reality. Annu. Rev. Microbiol. 56:167-185.
3. Audi, J., M. Belson, M. Patel, J. Schier, and J. Osterloh. 2005. Ricin poisoning: a comprehensive review. JAMA 294:2342-2351.
4. Baenziger, J. U., and D. Fiete. 1979. Structural determinants of Ricinus communis agglutinin and toxin specificity for oligosaccharides. J. Biol. Chem. 254:9795-9799.
5. Brandtzaeg, P. 2003. Role of secretory antibodies in the defence against infections. Int. J. Med. Microbiol. 293:3-15.
6. Brown, R. F., and D. E. White. 1997. Ultrastructure of rat lung following inhalation of ricin aerosol. Int. J. Exp. Pathol. 78:267-276.
7. Casadevall, A. 2002. Passive antibody administration (immediate immunity) as a specific defense against biological weapons. Emerg. Infect. Dis. 8:833-841.
8. Colombatti, M., A. Pezzini, and A. Colombatti. 1986. Monoclonal antibodies against ricin: effects on toxin function. Hybridoma 5:9-19.
9. Endo, Y., K. Mitsui, M. Motizuki, and K. Tsurugi. 1987. The mechanism of action of ricin and related toxins on eukaryotic ribosomes. J. Biol. Chem. 262:5908-5912.
10. Ferrari, M., M. C. Fornasiero, and A. M. Isetta. 1990. MTT colorimetric assay for testing macrophage cytotoxic activity in vitro. J. Immunol. Methods 131:165-172.
11. Frey, A., K. T. Giannasca, R. Weltsin, P. J. Giannasca, H. Reggio, W. I. Lencer, and M. R. Neutra. 1996. Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: implications for microbial attachment and vaccine targeting. J. Exp. Med. 184:1045-1059.
12. Giannasca, K. T., P. J. Giannasca, and M. R. Neutra. 1996. Adherence of Salmonella typhimurium to Caco-2 cells: identification of a glycoconjugate receptor. Infect. Immun. 64:135-145.
13. Giannasca, P. J., K. T. Giannasca, P. Falk, J. I. Gordon, and M. R. Neutra. 1994. Regional differences in glycoconjugates of intestinal M cells in mice: potential targets for mucosal vaccines. Am. J. Physiol. 267:G1108-G1121.
14. Gonzalez, T. V., S. A. Farrant, and N. J. Mantis. 2006. Ricin induces IL-8 secretion in human monocyte/macrophages by activating the p38 MAP kinase pathway. Mol. Immunol. 43:1920-1923.
15. Griffiths, G. D., S. C. Bailey, J. L. Hambrook, M. Keyte, P. Jayasekera, J. Miles, and E. Williamson. 1997. Liposomally-encapsulated ricin toxoid vaccine delivered intratracheally elicits a good immune response and protects against a lethal pulmonary dose of ricin toxin. Vaccine 15:1933-1939.
16. Griffiths, G. D., G. J. Phillips, and S. C. Bailey. 1999. Comparison of the quality of protection elicited by toxoid and peptide liposomal vaccine formulations against ricin as assessed by markers of inflammation. Vaccine 17:2562-2568.
17. Harlow, E., and D. Lane. 1988. Antibodies: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor. N.Y.
18. Harlow, E., and D. Lane. 1999. Using antibodies. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
19. Hewetson, J. F., V. R. Rivera, D. A. Creasia, P. V. Lemley, M. K. Rippy, and M. A. Poli. 1993. Protection of mice from inhaled ricin by vaccination with ricin or by passive treatment with heterologous antibody. Vaccine 11:743-746.
20. Hutchings, A. B., A. Helander, K. J. Silvey, K. Chandran, W. T. Lucas, M. L. Nibert, and M. R. Neutra. 2004. Secretory immunoglobulin A antibodies against the sigma 1 outer capsid protein of reovirus type 1 Lang prevent infection of mouse Peyer's patches. J. Virol. 78:947-957.
21. Kende, M., G. D. Giudice, N. Rivera, and J. Hewetson. 2006. Enhancement of intranasal vaccination in mice with deglycosylated chain A ricin by LTR72, a novel mucosal adjuvant. Vaccine 24:2213-2221.
22. Kende, M., C. Yan, J. Hewetson, M. A. Frick, W. L. Rill, and R. Tammariello. 2002. Oral immunization of mice with ricin toxoid vaccine encapsulated in polymeric microspheres against aerosol challenge. Vaccine 20:1681-1691.
23. Konowalchuk, J., J. I. Speirs, and S. Stavric. 1977. Vero response to a cytotoxin of Escherichia coli. Infect. Immun. 18:775-779.
24. Limley, P. V., P. Amanatides, and D. C. Wright. 1994. Identification and characterization of a monoclonal antibody that neutralizes ricin toxicity in vitro and in vivo. Hybridoma 13:417-421.
25. Lord, J. M., E. Decks, C. J. Marsden, K. Moore, C. Pateman, D. C. Smith, R. A. Spooner, P. Watson, and L. M. Roberts. 2003. Retrograde transport of toxins across the endoplasmic reticulum membrane. Biochem. Soc. Trans. 31:1260-1262.
26. Maddaloni, M., C. Cooke, R. Wilkinson, A. V. Stout, L. Eng, and S. H. Pincus. 2004. Immunological characteristics associated with the protective efficacy of antibodies to ricin, J. Immunol. 172:6221-6228.
27. Mantis, N. J. 2005. Vaccines against the category B toxins: staphylococcal enterotoxin B, epsilon toxin and ricin. Adv. Drug Deliv. Rev. 57:1424-1439.
28. Mantis, N. J., S. A. Farrant, and S. Mehta. 2004. Oligosaccharide side chains on human secretory IgA serve as receptors for ricin. J. Immunol. 172:6838-6845.
29. McHugh, C. A., R. F. Tammariello, C. B. Millard, and J. H. Carra. 2004. Improved stability of a protein vaccine through elimination of a partially unfolded state. Protein Sci. 13:2736-2743.
30. Mestecky, J., M. W. Russell, and C. O. Elson. 1999. Intestinal IgA: novel views on its function in the defence of the largest mucosal surface. Gut 44:2-5.
31. Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65:55-63.
32. Olsnes, S., A. M. Pappenheimer, Jr., and R. Meren. 1974. Lectins from Abrus precatorius and Ricinus communis. II. Hybrid toxins and their interaction with chain-specific antibodies. J. Immunol. 113:842-847.
33. Peterson, M. D., and M. S. Mooseker. 1992. Characterization of the enterocyte-like brush border cytoskeleton of the Caco-2BBe clone of the human intestinal cell line Caco-2. J. Cell Sci. 102:581-600.
34. Poli, M. A., V. R. Rivera, M. L. Pitt, and P. Vogel. 1996. Aerosolized specific antibody protects mice from lung injury associated with aerosolized ricin exposure. Toxicon 34:1037-1044.
35. Rainey, G. J., and J. A. Young. 2004. Antitoxins: novel strategies to target agents of bioterrorism. Nat. Rev. Microbiol. 2:721-726.
36. Rapak, A., P. O. Falnes, and S. Olsnes. 1997. Retrograde transport of mutant ricin to the endoplasmic reticulum with subsequent translocation to cytosol. Proc. Natl. Acad. Sci. USA 94:3783-3788.
37. Rutenber, E., M. Ready, and J. D. Robertus. 1987. Structure and evolution of ricin B chain. Nature 326:624-626.
38. Sandvig, K., S. Grimmer, S. U. Lauvrak, M. L. Torgersen, G. Skretting, B. van Deurs, and T. G. Iversen. 2002. Pathways followed by ricin and Shiga toxin into cells. Histochem. Cell Biol. 117:131-141.
39. Sekine, I., Y. Kawase, I. Nishimori, M. Mitarai, H. Harada, M. Ishiguro, and M. Kikutani. 1986. Pathological study on mucosal changes in small intestine of rat by oral administration of ricin. I. Microscopical observation. Acta Pathol. Jpn. 36:1205-1212.
40. Smallshaw, J. E., J. A. Richardson, S. Pincus, J. Schindler, and E. S. Vitetta. 2005. Preclinical toxicity and efficacy testing of RiVax, a recombinant protein vaccine against ricin. Vaccine 23:4775-4784.
41. Sphyris, N., J. M. Lord, R. Wales, and L. M. Roberts. 1995. Mutational analysis of the Ricinus lectin B-chains. Galactose-binding ability of the 2 gamma subdomain of Ricinus communis agglutinin B-chain. J. Biol. Chem. 270:20292-20297.
42. Tzipori, S., A. Sheoran, D. Akiyoshi, A. Donohue-Rolfe, and H. Trachtman. 2004. Antibody therapy in the management of Shiga toxin-induced hemolytic-uremic syndrome. Clin. Microbiol. Rev. 17:926-941.
43. van Deurs, B., S. H. Hansen, O. W. Petersen, E. L. Melby, and K. Sandvig. 1990. Endocytosis, intracellular transport and transcytosis of the toxic protein ricin by a polarized epithelium. Eur. J. Cell Biol. 51:96-109.
44. van Deurs, B., T. I. Tonnessen, O. W. Petersen, K. Sandvig, and S. Olsnes. 1986. Routing of internalized ricin and ricin conjugates to the Golgi complex. J. Cell Biol. 102:37-47.
45. Wilhelmsen, C. L., and M. L. Pitt. 1996. Lesions of acute inhaled lethal ricin intoxication in rhesus monkeys. Vet. Pathol. 33:296-302.
46. Yan, C., W. L. Rill, R. Malli, J. Hewetson, H. Naseem, R. Tammariello, and M. Kende. 1996. Intranasal stimulation of long-lasting immunity against aerosol ricin challenge with ricin toxoid vaccine encapsulated in polymeric microspheres. Vaccine 14:1031-1038.
47. Youle, R. J., and M. Colombatti. 1987. Hybridoma cells containing intracellular antiricin antibodies show ricin meets secretory antibody before entering the cytosol. J. Biol. Chem. 262:4676-4682.